LDS/Medical Tests/Chlamydia trachomatis and Neisseria gonorrhoeae NA, Urine

Chlamydia trachomatis and Neisseria gonorrhoeae NA, Urine

Chlamydia trachomatis and Neisseria gonorrhoeae are the most common causes of sexually transmitted disease. An estimated 3 million Chlamydia trachomatis infections occur annually among sexually active adolescents and young adults in the United States. The majority of persons with C. trachomatis and N. gonorrhoeae infection are not aware of their infection because they are asymptomatic.

Untreated disease can lead to serious complications including pelvic inflammatory disease and infertility in women. C. trachomatis and N. gonorrhoeae infection during pregnancy can lead to infant conjunctivitis and pneumonia as well as maternal postpartum endometritis. Among men, urethritis and epididymitis are the most common illnesses resulting from C. trachomatis infection. Consequently, screening is necessary to identify and treat these infections. The US Preventive Services Task Force strongly recommends routine C. trachomatis and N. gonorrhoeae screening for all sexually active women 25 years of age or younger, as well as for pregnant women and others at increased risk.

Culture testing for C. trachomatis and N. gonorrhoeae has been the reference standard against which all other tests have been compared. However, other tests are needed because culturing for C. trachomatis is difficult to standardize, technically demanding, and expensive. In addition, culturing of either agent is associated with problems in maintaining the viability of organisms during transport and storage. Molecular testing for C. trachomatis and N. gonorrhoeae infection has become a gold standard methodology with the highest sensitivity and specificity.

  • Screening for Chlamydia trachomatis infection such as cervicitis, pelvic inflammatory disease (PID), urethritis and epididymitis in men and other sexually transmitted disease
  • As an aid in diagnosis of trachoma, conjunctivitis, pneumonia
  • Screening for Neisseria gonorrhea infection in cervicitis, pelvic inflammatory disease, urethritis, infertility and other sexually transmitted diseases
  • Useful in confirmation testing for diagnosis of Chlamydia trachomatis and/or Neisseria gonorrhea infections

Positive (Detected):

  • Chlamydia trachomatis and Neisseria gonorrhea infection

Negative (Not Detected)

 

Transcription Mediated Amplification (TMA) technology, Polymerase Chain Reaction (PCR).

ThinPrep™ Solution or Digene STM, urine, culture swabs in M4 transport medium. Specimens are stable at room temperature.

C. trachomatis and N. gonorrhoeae infection culture if indicated, PAP smear, Human papillomavirus (HPV) by molecular method, Herpes simplex virus by molecular method.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login